Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002007317-25-000028
Filing Date
2025-01-23
Accepted
2025-01-23 16:43:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3538
  Complete submission text file 0002007317-25-000028.txt   5281
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Subject) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 144 | Act: 33 | File No.: 001-38042 | Film No.: 25550673
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3621 SOUTH STATE ST 695 KMS PL ANN ARBOR MI 48108
Business Address
OLUKOTUN ADEOYE Y (Reporting) CIK: 0001242615 (see all company filings)

Type: 144